DrugSupplement
Alanylglutamine clinical trials
- studies test it
- 20
- open now
- 1
- in phase 3
- 8
- first study started
- 2001
Keep track of what changes. Save the alanylglutamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Combined with it in one product
Studies by the year they started
20 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
- Phase 3
- 8
- Phase 4
- 4
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 19
University of Virginia (4) · Menoufia University (2) · University Hospital, Rouen (1) · Centre Hospitalier Universitaire de Besancon (1) · Cairo University (1) · National Cardiovascular Center Harapan Kita Hospital Indonesia (1) · Institute of Child Health (1) · Temple Therapeutics BV (1)
Often tested with
Tested in the same studies.
Glycine (2) · Omega-3 fatty acid (1) · Bunitrolol hydrochloride (1) · Total Parenteral Nutrition (1) · Fish oil triglycerides (1)
Studies
Open first, then newest update. How each study uses alanylglutamine is read from its arms, and is right about nine times in ten.
Testing it · 20
- Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)RecruitingPhase 2University of VirginiaNCT04305769Written as Alanyl-glutamine
- Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature NeonatesCompletedPhase 4University Hospital, RouenNCT00213668Written as glutamine (dipeptiven)
- Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill PatientsCompletedNot applicableCentre Hospitalier Universitaire de BesanconNCT03967795Written as N2-L-Alanyl-L-Glutamine (Substance)
- Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular TumoursCompletedNot applicableCairo UniversityNCT06339372Written as Omega 3 and dipeptiven
- Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical CystectomyCompletedNot applicableMenoufia UniversityNCT05822518Written as Dipeptiven solution (Fresenius Kabi pharmaceutical)
- Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EFCompletedPhase 3National Cardiovascular Center Harapan Kita Hospital IndonesiaNCT04560309Written as L-alanyl-L-glutamine dipeptide
- Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill PatientsStatus unknownNot applicableAir Force Specialized Hospital, Cairo, EgyptNCT05586646Written as alanyl-glutamine
- Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile InfectionTerminatedPhase 2University of VirginiaNCT02053350Written as Alanyl-glutamine
- Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving GlutamineCompletedPhase 4Institute of Child HealthNCT00647036Written as Dipeptiven (L-glutamine- Lalanine)
- Glutamine Effects in Burn PatientsStatus unknownPhase 2/3Menoufia UniversityNCT05140772Written as Dipeptiven
- A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy AdhesionsCompletedPhase 1/2Temple Therapeutics BVNCT01701193Written as L-Alanyl/L-Glutamine
- Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of GlutamineCompletedPhase 3University Hospital MuensterNCT04019184Written as L-Alanyl/L-Glutamine
- Efficacy and Mechanisms of GLN Dipeptide in the SICUCompletedPhase 3Emory UniversityNCT00248638Written as Glutamine dipeptide with 15% Clinisol
- Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and EnteropathyCompletedPhase 3Children's Hospital Medical Center, CincinnatiNCT01832636Written as Alanyl-Glutamine
- Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal DialysisTerminatedPhase 1/2Christoph AufrichtNCT01353638Written as Dipeptiven (Alanyl-glutamine-dipeptide)
- Optimized Therapy in Severe Traumatic Brain Injured PatientsCompletedPhase 4University of ZurichNCT02130674Written as Dipeptiven
- The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral NutritionStatus unknownPhase 3Royal Brisbane and Women's HospitalNCT01240291Written as Dipeptiven
- HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or MalnutritionWithdrawnPhase 3University of VirginiaNCT00133562Written as Alanyl-glutamine
- Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or MalnutritionWithdrawnPhase 3University of VirginiaNCT00338221Written as alanyl-glutamine
- The Impact of Immunostimulating Nutrition on the Outcome of SurgeryCompletedPhase 4Jagiellonian UniversityNCT00558155Written as Omegaven, Dipeptiven
Codes
What other systems call alanylglutamine · ClinicalTrials.gg INT003354
- MeSH (NLM) C054122alanylglutamineOne source NLM
- UNII (FDA) U5JDO2770ZALANYL GLUTAMINEConfirmed FDA, NLM
- RxNorm 1359422One source FDA
- NCI Thesaurus C127908AlanylglutamineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C054122 | alanylglutamine | One source NLM |
| UNII (FDA) | U5JDO2770Z | ALANYL GLUTAMINE | Confirmed FDA, NLM |
| RxNorm | 1359422 | — | One source FDA |
| NCI Thesaurus | C127908 | Alanylglutamine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.